Sign in
Download Opera News App

HEALTH COVID

Study demonstrates effectiveness of two doses of BBV152 vaccine against COVID-19

Study demonstrates effectiveness of two doses of BBV152 vaccine against COVID-19

On January 16, 2021, India launched its coronavirus disease 2019 (COVID-19) vaccination campaign with two vaccines: Oxford–AstraZeneca ChAdOx1 nCoV-19 (a chimp adenoviral vector vaccine manufactured by Serum Institute of India; Covishield) and BBV152 (a whole-virion inactivated vaccine manufactured by Bharat Biotech; Covaxin). Study: Effectiveness of an inactivated virus-based SARS-CoV-2 vaccine, BBV152,...

Read Full Story
BBV152 Covaxin India Oxford AstraZeneca SARS-CoV-2 Viacheslav Lopatin

Top News

US POLITICS

US intelligence estimates Russian troop levels on Ukraine border could reach 175,000

edition.cnn.com
US intelligence estimates Russian troop levels on Ukraine border could reach 175,000

US POLITICS

US intelligence estimates Russian troop levels on Ukraine border could reach 175,000

edition.cnn.com

MURDER

Michigan school shooting suspect's parents plead not guilty

cnn.com
Michigan school shooting suspect's parents plead not guilty

MURDER

Michigan school shooting suspect's parents plead not guilty

cnn.com

comments

Load app to read more comments